Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,236.00-0.99%ETH$2,242.59-0.43%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
Becton, Dickinson and Company logo

NYSE · BDX

Becton, Dickinson and Company

Healthcare · Medical - Instruments & Supplies

$198.34

Down-$0.46 (-0.23%)

Updated Oct 30, 2026, 11:01 PM

SID Score

5.9/10

Composite research score

Smart Money

47/100

Neutral

Market cap
57.44B
P/E ratio
34.23
Dividend yield
2.10%
52-week range
$140.11 – $213.08
Volume
2.2M
Avg. volume
1.98M

Price performance · BDX

BDX price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

BDX closed at $198.34 after 21 trading sessions, up 11.38% for the selected period.

Last close
$198.34
Period change
+11.38%
Period low
$176.80
Period high
$200.42
Daily close
View OHLC price history
BDX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$197.11$198.64$194.53$198.342.2M
Oct 28, 2026$194.22$196.88$193.80$195.161.74M
Oct 27, 2026$194.77$196.16$194.095$195.031.15M
Oct 26, 2026$198.13$198.90$194.71$196.391.64M
Oct 23, 2026$199.18$200.42$197.15$198.911.3M
Oct 22, 2026$195.35$200.47$194.91$200.421.38M
Oct 21, 2026$191.72$195.22$191.72$194.341.07M
Oct 20, 2026$192.78$193.85$191.345$193.801.08M
Oct 19, 2026$190.10$191.86$189.49$190.741.22M
Oct 16, 2026$194.42$195.99$190.21$191.751.41M
Oct 15, 2026$192.00$194.34$189.505$193.761.97M
Oct 14, 2026$188.26$189.675$186.04$188.891.65M
Oct 13, 2026$189.82$189.99$185.59$187.371.15M
Oct 12, 2026$184.32$188.92$184.32$188.891.18M
Oct 9, 2026$181.89$183.85$181.51$183.751.62M
Oct 8, 2026$179.76$182.76$178.90$182.751.52M
Oct 7, 2026$180.34$182.38$177.915$180.161.92M
Oct 6, 2026$183.35$187.45$180.1219$180.302.05M
Oct 5, 2026$176.58$180.90$176.04$180.671.64M
Oct 2, 2026$177.46$178.13$175.71$176.801.87M
Oct 1, 2026$179.11$179.665$177.02$178.071.29M

Latest BDX news

The latest Smart Investors Daily articles mentioning BDX.

Stock researchCompany · Overview

BDX research

Overview

Company profile and research snapshot.

Company profile

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$210.00
Implied upside
—
Analysts
15
BDX recent ratings
DateFirmRatingTarget
Oct 7, 2026BarclaysUnderweight—
Aug 31, 2026B of A SecuritiesNeutral—
Aug 13, 2026RBC CapitalSector Perform—
Aug 7, 2026Piper SandlerNeutral—
Aug 7, 2026RBC CapitalSector Perform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 23, 2026

What Becton Dickinson Stock's New U.S. Manufacturing Deal Means For Shareholders

Becton Dickinson has seen stronger performance in its high growth segments, supported by ongoing product development, clinical trial progress, and a major U.S. manufacturing agreement that was announced before the scheduled fiscal 2026 fourth quarter earnings release on 5 November. The combination of a new domestic manufacturing deal and clinical milestones reinforces Becton Dickinson’s push toward higher value medtech platforms with recurring demand exposure. We will now look at how Becton...

Yahoo · Oct 23, 2026

Becton Dickinson (BDX) Stock Trades Below Fair Value After A 40% Run

Becton Dickinson has delivered a strong share price run over the past year, which puts fresh focus on whether the current US$200.42 level is grounded in the cash it can generate. For anyone looking at the stock today, the central issue is how that recent performance lines up with the cash flow profile implied by its existing business. The share price return of 40.1% over the past year puts real pressure on the question of whether the valuation still lines up with the cash the business can...

Yahoo · Oct 23, 2026

Is Becton Dickinson (BDX) Fully Priced As Execution Improves Before Earnings?

Becton Dickinson (BDX) heads into its fourth quarter fiscal 2026 report with investors focused on recent execution improvements, progress in higher growth businesses, fresh product launches, and a major U.S. manufacturing agreement. Becton Dickinson’s recent news arrives after a strong run in the market, with the share price up 28.18% over the past 90 days and a 1-year total shareholder return of 40.14%. This points to building momentum as investors reassess its execution, pipeline progress,...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By